Skip Navigation Archive: U.S. Department of Health and Human Services U.S. Department of Health and Human Services
Archive: Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home—Live Site | Archive Home | Site Map
Archival print banner

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to www.ahrq.gov for current information.

36. AHRQ Research Effort Informs Drug Safety

Director's Update

Text version of slide presentation from a National Advisory Council meeting.

Text Description is below the image.

  • Zuvekas and Vitiello: Trends in Stimulant Medication Use Among U.S. Children:
    • Presented to FDA [Food and Drug Administration] Drug Safety Oversight Board.
    • Earlier version presented at an FDA Pediatric Advisory Committee meeting.
    • Informed decision on black box warnings for stimulant medications at the time.

 

Previous Slide         Contents         Next Slide

Page last reviewed August 2011
Page originally created September 2012
Internet Citation: 36. AHRQ Research Effort Informs Drug Safety. Content last reviewed August 2011. Agency for Healthcare Research and Quality, Rockville, MD. https://archive.ahrq.gov/news/events/nac/2011-04-nac/clancy/slide36.html

 

The information on this page is archived and provided for reference purposes only.

 
AHRQ Advancing Excellence in Health Care